Antimicrobial agent-61
Antimicrobial agent-61 is an Antimicrobial agent. Antimicrobial agent-61 induces bacterial membrane depolarization and inhibits ATP synthesis. Antimicrobial agent-61 reduces bacterial burden and infection-related pathological damage in mouse models of MRSA pneumonia and MRSA keratitis. Antimicrobial agent-61 can be used for research on MRSA pneumonia and MRSA keratitis.
For research use only. We do not sell to patients.
- CAS No.: 313495-77-1
- Formula: C15H7Br2F6NO2
- Molecular Weight:507.02
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
Antimicrobial agent-61 (Compound D2) (0.195-25 μg/mL; 16-18 h) exhibits potent activity against Gram-positive pathogens and MRSA, with an MIC of 1.6 μg/mL against S. aureus ATCC 25923 and an MIC of 0.8 μg/mL against MRSA ATCC 43300[1].
Antimicrobial agent-61 (4× MIC; 0-26 h) exerts a time-dependent bactericidal effect and completely eradicates S. aureus within 26 h[1].
Antimicrobial agent-61 (0.25×-0.5× MIC; 30-60 min) induces significant membrane depolarization in S. aureus at subinhibitory concentrations of 0.25× and 0.5× MIC within 30-60 min[1].
Antimicrobial agent-61 (1×-4× MIC; 30 min) reduces intracellular ATP in S. aureus at 4× MIC[1].
Antimicrobial agent-61 (3.125-12.5 μg/mL; 90 min) does not compromise the inner membrane integrity of E. coli mL-35[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
In Vivo
Antimicrobial agent-61 (1 mg/mL; topical ocular; every 5 min for the first hour, then every 30 min for the subsequent 7 h) reduces corneal bacterial burden and attenuates infection-associated pathology in a murine MRSA keratitis model[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Kunming (female, 22 g)[1]
-
Dosage:5 mg/kg
-
Administration:i.p.; at 2 h and 12 h post-infection
-
Result:D2-treated mice had lung bacterial burden Log10 (CFU/mL) = 6.353.
Reduced lung bacterial burden by 0.63 log10 relative to the model group.
-
Animal Model:Kunming (male, 22 g)[1]
-
Dosage:1 mg/mL
-
Administration:topical ocular; every 5 min for the first hour, then every 30 min for the subsequent 7 h
-
Result:D2-treated mice had corneal bacterial load Log10 (CFU/mL) = 5.804.
Chemical Information
-
CAS No. 313495-77-1
-
Molecular Weight 507.02
-
Formula C15H7Br2F6NO2
-
SMILES
O=C(C1=C(O)C(Br)=CC(Br)=C1)NC2=CC(C(F)(F)F)=CC=C2C(F)(F)F
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
Fluorescent plasma-membrane potential dye assay
Fluorescent plasma-membrane potential dye assays measure changes in cell membrane potential using voltage-sensitive dyes whose fluorescence changes when cells depolarize or hyperpolarize. Anionic bis-oxonol dyes such as DiBAC4(3) enter depolarized cells more readily and show increased fluorescence after intracellular binding, while hyperpolarization reduces dye accumulation and fluorescence. FMP/FLIPR membrane-potential dyes are used for faster, homogeneous microplate assays of ion-channel or receptor-mediated membrane-potential changes.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)